Those with the BRCA1 gene mutation may face greater risk for aggressive cancer caused by asbestos exposure

byNagoya UniversityChrysotile-induced MMs present lower expression levels of Brca1. (A) Immunohistochemistry (IHC) staining of total BRCA1 on MM samples (bar=25 μm; N≧7).

Updated on: January 02,2024

Those with the BRCA1 gene mutation may face greater risk for aggressive cancer caused by asbestos exposure

byNagoya UniversityChrysotile-induced MMs present lower expression levels of Brca1. (A) Immunohistochemistry (IHC) staining of total BRCA1 on MM samples (bar=25 μm; N≧7).

Updated on:January 02,2024

Researchers discover a new way to improve the assessment of prostate cancer aggressiveness

by Queen's University BelfastCredit: Queen's University BelfastResearchers from Queen's University Belfast have discovered a new way to predict the aggressiveness and future behavior

Updated on: June 19,2024

Researchers discover a new way to improve the assessment of prostate cancer aggressiveness

by Queen's University BelfastCredit: Queen's University BelfastResearchers from Queen's University Belfast have discovered a new way to predict the aggressiveness and future behavior

Updated on:June 19,2024

Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo

Updated on: October 21,2024

Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo

Updated on:October 21,2024

Study reveals CREB3's role in hepatocellular carcinoma suppression via AKT signaling

by Sichuan International Medical Exchange and Promotion AssociationExpression of CREB3 is decreased in HCC tissues and correlated with better clinical outcome. (A) mRNA expression of CREB3 in HCC tiss

Updated on: July 05,2024

Study reveals CREB3's role in hepatocellular carcinoma suppression via AKT signaling

by Sichuan International Medical Exchange and Promotion AssociationExpression of CREB3 is decreased in HCC tissues and correlated with better clinical outcome. (A) mRNA expression of CREB3 in HCC tiss

Updated on:July 05,2024

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Updated on: November 09,2024

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Updated on:November 09,2024

Stopping the resistance of cancer cells to treatment

by Colin Poitras,University of ConnecticutCredit: CC0 Public DomainOne of the drawbacks of chemotherapy is that cancer patients can build up resistance to treatment over time, increasing their c

Updated on: April 01,2024

Stopping the resistance of cancer cells to treatment

by Colin Poitras,University of ConnecticutCredit: CC0 Public DomainOne of the drawbacks of chemotherapy is that cancer patients can build up resistance to treatment over time, increasing their c

Updated on:April 01,2024

Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su

Updated on: February 03,2024

Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su

Updated on:February 03,2024

Evolving insights in blood-based liquid biopsies for prostate cancer interrogation

by Impact Journals LLCAnalysis of blood-based liquid biopsies in prostate cancer. Credit:Oncoscience(2023). DOI: 10.18632/oncoscience.592A new research perspective was published inOn

Updated on: January 02,2024

Evolving insights in blood-based liquid biopsies for prostate cancer interrogation

by Impact Journals LLCAnalysis of blood-based liquid biopsies in prostate cancer. Credit:Oncoscience(2023). DOI: 10.18632/oncoscience.592A new research perspective was published inOn

Updated on:January 02,2024

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel

Updated on: January 11,2024

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel

Updated on:January 11,2024

What you need to know about flu vaccination if you have cancer

by Laurel Kelly,Mayo ClinicCredit: Unsplash/CC0 Public DomainAs flu season approaches, it's important to understand the need to get vaccinated for influenza, or flu. Indications are it could

Updated on: January 02,2024

What you need to know about flu vaccination if you have cancer

by Laurel Kelly,Mayo ClinicCredit: Unsplash/CC0 Public DomainAs flu season approaches, it's important to understand the need to get vaccinated for influenza, or flu. Indications are it could

Updated on:January 02,2024

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

Updated on: March 05,2024

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

Updated on:March 05,2024

Smoking is an undertreated risk factor after a cancer diagnosis

by American College of SurgeonsBaseline survey results of a national quality improvement project led by the American College of Surgeons describe the many challenges and missed opportunities thes

Updated on: March 20,2024

Smoking is an undertreated risk factor after a cancer diagnosis

by American College of SurgeonsBaseline survey results of a national quality improvement project led by the American College of Surgeons describe the many challenges and missed opportunities thes

Updated on:March 20,2024